Box 24.1The 54th World Health Assembly

The 54th World Health Assembly, which met in May 2001, urged member states to ensure access to essential drugs for schistosomiasis and STH infections in endemic areas for the treatment of clinical cases and groups at high risk for morbidity. The helminth infections of concern are the major schistosomes and STHs outlined in the text. The World Health Assembly determined that simple and sustainable control measures can relieve a generally underestimated and unnecessary disease burden in high-transmission areas. The following minimal targets, aimed at reducing morbidity by 80 percent, can be achieved by all countries in which such disease is endemic as an integral part of the primary health care system: (a) access to adequate diagnosis and essential anthelmintic drugs in all health services in all endemic areas, even at peripheral levels, for the treatment of symptomatic cases and of children, women, and other groups at high risk of morbidity; (b) regular administration of chemotherapy to at least 75 percent of all school-age children at risk for morbidity by 2010; and (c) sustained, community-based efforts to improve sanitation, clean water supplies, and health education.

Source: WHO 2002.

From: Chapter 24, Helminth Infections: Soil-transmitted Helminth Infections and Schistosomiasis

Cover of Disease Control Priorities in Developing Countries
Disease Control Priorities in Developing Countries. 2nd edition.
Jamison DT, Breman JG, Measham AR, et al., editors.
Washington (DC): World Bank; 2006.
Copyright © 2006, The International Bank for Reconstruction and Development/The World Bank Group.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.